XML 50 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6
Derivative Financial Instruments
6 Months Ended
Jun. 30, 2012
Derivative Financial Instruments  
Derivative Financial Instruments

Note 10.  Derivative Financial Instruments

 

The following table presents the Company’s derivative financial instruments, their fair values, and balance sheet location as of June 30, 2012 and December 31, 2011:

 

 

 

June 30, 2012

 

December 31, 2011

Derivative Financial Instruments Not Designated
as Hedging Instruments1 (dollars in thousands)

 

Asset
Derivatives

 

Liability
Derivatives

 

 

Asset
Derivatives

 

Liability
Derivatives

Interest Rate Lock Commitments

 

$

7,377

 

$

-

 

 

$

2,344

 

$

10

Forward Commitments

 

37

 

1,799

 

 

8

 

946

Interest Rate Swap Agreements

 

35,296

 

35,567

 

 

35,503

 

35,779

Foreign Exchange Contracts

 

156

 

125

 

 

230

 

97

Total

 

$

42,866

 

$

37,491

 

 

$

38,085

 

$

36,832

 

1  Asset derivatives are included in other assets and liability derivatives are included in other liabilities in the consolidated statements of condition.

 

The following table presents the Company’s derivative financial instruments and the amount and location of the net gains or losses recognized in the statements of income for the three and six months ended June 30, 2012 and 2011:

 

 

 

Location of Net Gains

 

Three Months Ended

 

 

Six Months Ended

Derivative Financial Instruments Not Designated

 

(Losses) Recognized in the

 

June 30,

 

 

June 30,

as Hedging Instruments  (dollars in thousands)

 

Statement of Income

 

2012

 

2011

 

 

2012

 

2011

 

Interest Rate Lock Commitments

 

Mortgage Banking

 

  $

 9,363

 

  $

 1,908

 

 

  $

 13,066

 

  $

 3,389

 

Forward Commitments

 

Mortgage Banking

 

(2,028

)

(341

)

 

(1,762

)

(105

)

Interest Rate Swap Agreements

 

Other Noninterest Income

 

(11

)

339

 

 

5

 

367

 

Foreign Exchange Contracts

 

Other Noninterest Income

 

713

 

743

 

 

1,580

 

1,640

 

Total

 

 

 

  $

 8,037

 

  $

 2,649

 

 

  $

 12,889

 

  $

 5,291

 

 

Management has received authorization from the Bank’s Board of Directors to use derivative financial instruments as an end-user in connection with its risk management activities and to accommodate the needs of its customers.  As with any financial instrument, derivative financial instruments have inherent risks.  Market risk is defined as the risk of adverse financial impact due to fluctuations in interest rates, foreign exchange rates, and equity prices.  Market risks associated with derivative financial instruments are balanced with the expected returns to enhance earnings performance and shareholder value, while limiting the volatility of each.  The Company uses various processes to monitor its overall market risk exposure, including sensitivity analysis, value-at-risk calculations, and other methodologies.

 

Derivative financial instruments are also subject to credit and counterparty risk, which is defined as the risk of financial loss if a borrower or counterparty is either unable or unwilling to repay borrowings or settle a transaction in accordance with the underlying contractual terms.  Credit and counterparty risks associated with derivative financial instruments are similar to those relating to traditional financial instruments.  The Company manages derivative credit and counterparty risk by evaluating the creditworthiness of each borrower or counterparty, adhering to the same credit approval process used for commercial lending activities.

 

Derivative financial instruments are required to be carried at their fair value on the Company’s consolidated statements of condition.  As of June 30, 2012 and December 31, 2011, the Company did not designate any derivative financial instruments in formal hedging relationships.  The Bank’s free-standing derivative financial instruments have been recorded at fair value on the Company’s consolidated statements of condition.  These financial instruments have been limited to interest rate lock commitments (“IRLCs”), forward commitments, interest rate swap agreements, and foreign exchange contracts.

 

The Company enters IRLCs for residential mortgage loans which commit us to lend funds to a potential borrower at a specific interest rate and within a specified period of time.  IRLCs that relate to the origination of mortgage loans that will be held for sale are considered derivative financial instruments under applicable accounting guidance.  Outstanding IRLCs expose the Company to the risk that the price of the mortgage loans underlying the commitments may decline due to increases in mortgage interest rates from inception of the rate lock to the funding of the loan.  To mitigate this risk, the Company utilizes forward commitments as economic hedges against the potential decreases in the values of the loans held for sale.  The IRLCs and forward commitments are free-standing derivatives which are carried at fair value with changes recorded in the mortgage banking component of noninterest income in the Company’s consolidated statements of income.  Changes in the fair value of IRLCs and forward commitments subsequent to inception are based on changes in the fair value of the underlying loan resulting from the fulfillment of the commitment and changes in the probability that the loan will fund within the terms of the commitment, which is affected primarily by changes in interest rates and the passage of time.

 

The Company enters into interest rate swap agreements to facilitate the risk management strategies of a small number of commercial banking customers.  The Company mitigates this risk by entering into equal and offsetting interest rate swap agreements with highly rated third party financial institutions.  The interest rate swap agreements are free-standing derivatives which are carried at fair value with changes included in other noninterest income in the Company’s consolidated statements of income.  The Company is party to master netting arrangements with its institutional counterparties; however, the Company does not offset assets and liabilities under these arrangements for financial statement presentation purposes.  Collateral, usually in the form of marketable securities, is posted by the counterparty with liability positions in accordance with contract thresholds.  The Company had net liability positions with its financial institution counterparties totaling $35.6 million and $35.8 million as of June 30, 2012 and December 31, 2011, respectively.  The collateral posted by the Company for these net liability positions was $2.9 million and $3.6 million as of June 30, 2012 and December 31, 2011, respectively.

 

The Company’s interest rate swap agreements with institutional counterparties contain credit-risk-related contingent features tied to the Company’s debt ratings or capitalization levels.  Under these provisions, if the Company’s debt rating falls below investment grade or if the Company’s capitalization levels fall below stipulated thresholds, certain counterparties may require immediate and ongoing collateralization on interest rate swaps in net liability positions, or may require immediate settlement of the contracts.  As of June 30, 2012, the Company’s debt ratings and capital levels were in excess of these minimum requirements.

 

The Company utilizes foreign exchange contracts to offset risks related to transactions executed on behalf of customers.  The foreign exchange contracts are free-standing derivatives which are carried at fair value with changes included in other noninterest income in the Company’s consolidated statements of income.